*Strides Pharma Science Ltd.* | *CMP* Rs. 540 | *M Cap* Rs. 4845 Cr | *52 W H/L* 1000/517
(Nirmal Bang Retail Research)
*Result is below expectations*
Revenue from Operations came at Rs. 721.5 Cr (4.8% QoQ, -9.1% YoY) vs expectation of Rs. 757.6 Cr, QoQ Rs. 688.4 Cr, YoY Rs. 793.6 Cr
EBIDTA came at Rs. -1.1 Cr (-98.1% QoQ, -100.7% YoY) vs expectation of Rs. 37.3 Cr, QoQ Rs. -55.4 Cr, YoY Rs. 157.2 Cr
EBITDA Margin came at -0.1% vs expectation of 4.9%, QoQ -8%, YoY 19.8%
Adj. PAT came at Rs. -108.1 Cr vs expectation of Rs. -53 Cr, QoQ Rs. -113.7 Cr, YoY Rs. 67.8 Cr
Quarter EPS is Rs. -12
Share is trading at P/E of 14x FY23E EPS